Sartorius | SRT3 - EPS Earnings Per Share

Stock Price
206.00
Daily Change
-7.50 -3.51%
Monthly
-9.65%
Yearly
-10.75%
Q2 Forecast
211.37

Sartorius reported EUR1.2 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 1.20 1.3 1.22 Apr/23
FY2025Q4 Dec/2025 1.27 1.33 1.04 Feb/03
FY2025Q3 Sep/2025 0.63 1.08 0.21 Oct/16
FY2025Q2 Jun/2025 0.47 1.28 0.34 Jul/22
FY2025Q1 Mar/2025 1.22 0.98 1.01 Apr/16




Eps Change Date
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Alaunos Therapeutics USD -0.53 0.08 Sep/2025
Avita Medical AUD -0.38 0 Dec/2025
Dianthus Therapeutics USD -1.43 0.46 Dec/2025
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
IQVIA Holdings USD 2.9 0.52 Mar/2026
Moderna USD -3.4 1.29 Mar/2026
Organon & Co USD 0.71 0.08 Mar/2026
Revvity USD 1.06 0.64 Mar/2026
Sartorius EUR 1.2 0.06 Mar/2026
Tectonic Therapeutic USD -1.03 0.01 Dec/2025
Viatris USD 0.59 0.02 Mar/2026
Xeris Pharmaceuticals USD 0.01 0.04 Mar/2026